Pfizer Is Worst-Performing US Large-Cap Pharma Stock This Year, Its Investment Case Is Complex Yet Rewarding

By: via Benzinga
Credit Suisse has initiated coverage onPfizer Inc(NYSE: PFE) with an Outperform rating and aprice target of ...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.